The results showed that clinically significant tumor shrinkage (≥20 %) was achieved in 63 % of patients and there were early and sustained improvements in growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels, acromegaly symptoms, and HRQoL [7]. The gene discussed is IGF1; the disease is neoplasm.